Last reviewed:
Without ART, chronic HIV often takes a decade or longer to progress to AIDS, but it can progress faster. CDC and NIH give about three years as a broad survival estimate for untreated AIDS. These figures cannot predict your lifespan or tell you it is safe to wait. Prompt treatment can protect health and greatly improve outcomes, even after advanced disease develops.[1][2][11]
A decade or longer — what the primary sources actually say
Without treatment, HIV generally progresses from acute infection through chronic infection to AIDS. CDC and NIH describe chronic HIV as potentially lasting a decade or longer, with faster progression in some people. Those broad descriptions concern disease stages; they are not a fixed countdown from an exposure.[1][2]
Historical cohort research also shows variation. A 2000 collaborative analysis from before widespread combination ART estimated median time from seroconversion to AIDS at 11.0 years for people aged 15–24 and 7.7 years for those aged 45–54. The study included pre-combination-treatment care, so it is not a clean experiment in never-treated people, and its estimates are not predictions for someone receiving modern ART.[3]
WHO defines advanced HIV disease in adults and adolescents by CD4 below 200 cells/mm³ or a WHO stage 3 or 4 event; all children under five with HIV are considered to have advanced disease. Current care uses clinical and laboratory findings, rather than counting years since infection.[4]
After a stage 3 diagnosis: about three years without treatment
CDC and NIH describe about three years as a typical survival estimate for untreated AIDS. Actual survival varies with opportunistic illnesses and other factors. This is not an estimate for people receiving effective ART.[1][2]
Treatment can help even when HIV is diagnosed at an advanced stage. Seek care promptly; the clinician will arrange ART and any needed treatment or prevention for opportunistic infections. A few infections, including cryptococcal or tuberculosis meningitis, affect the safest timing of ART.[11][2]
Why the timeline varies so much from person to person
Age, immune status, viral load and other health factors affect progression. Your clinician uses current health and test results to assess your situation.[5]
A small group of people maintain health or very low viral levels for long periods without ART. Long-term non-progression and elite viral control are related but distinct descriptions, and control may not last. NIH recommends ART for elite controllers too, with a shared discussion of the evidence and individual circumstances. Do not delay treatment to see whether you are an exception.[11][6]
The other timeline: what treatment actually buys
Prompt ART changes the outlook. In the START randomized trial, adults with CD4 counts above 500 were assigned to immediate treatment or deferral until CD4 fell to 350 or a treatment indication developed. Immediate ART reduced the combined outcome of serious AIDS events, serious non-AIDS events or death (hazard ratio 0.43). That is about a 57% relative reduction in that combined outcome, not a 57% reduction in death alone.[12][1]
A 2023 collaborative study followed 206,891 adults in Europe and North America who had survived at least one year on ART. Treated groups with high CD4 counts had life-expectancy estimates close to those of the general population. Results differed by age, sex, immune status and medical history. They cannot be combined with untreated stage durations to calculate an individual lifespan.[7]
Why testing is the whole ballgame
HIV can cause no symptoms for years. Testing establishes HIV status, and follow-up tests help assess immune health and treatment response. Testing alone does not stop progression: linkage to care and effective ART are what change the course of infection.[8]
CDC’s May 2026 release reports that among 38,434 people aged 13 or older diagnosed with HIV in the United States in 2024, 8,341 (21.7%) had stage 3 at diagnosis. It also reports 83.1% linked to care within one month and 71.1% virally suppressed within six months. These are provisional surveillance measures reported through December 2025, not treatment-success probabilities for an individual.[9]
Florida: 1,981 stage 3 diagnoses recorded in 2023
Florida recorded 1,981 stage 3 (AIDS) diagnoses in 2023, a rate of 8.7 per 100,000 — down from 2,174 diagnoses and 11.1 per 100,000 in 2014, but still close to two thousand people a year reaching advanced disease in one state[10]. Of the 128,497 people living with HIV in Florida in 2023, 79% were in care, 73% were retained in care, and 70% had a suppressed viral load — leaving roughly 3 in 10 without documented suppression[10].
These 2023 surveillance measures identify gaps in diagnosis and care, but they do not prove why each person developed advanced disease. Lack of documented suppression also does not necessarily mean a person’s treatment failed. Contact a local clinic or use our locator to ask about testing and prompt linkage to care; access and appointment timing vary.
Related questions
How long does it take for untreated HIV to become AIDS?
How long can someone live after an AIDS diagnosis without treatment?
Can anyone live with HIV long-term without medication?
Some people maintain health or very low viral levels without ART for unusually long periods. These uncommon patterns are studied as long-term non-progression or elite control; they do not guarantee future protection. NIH recommends ART for elite controllers as well, with individualized discussion and monitoring.[6][11]
What is life expectancy with HIV on treatment?
Related from RiseUpToHIV
References & Sources
- NIH HIVinfo — Stages of HIV Infection: broad untreated progression and survival estimates; treatment benefits. Source. ↩↩↩↩↩↩ ↩ ↩ ↩ ↩
- CDC — About HIV. CDC's statement that chronic HIV without treatment "may last a decade or longer," that people with AIDS typically survive about three years untreated, and that treatment should start as soon as possible. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
- Collaborative Group/CASCADE, Lancet (2000);355:1131–1137. Primary pooled cohort analysis of progression before widespread combination ART, including age-specific medians. Source. ↩ ↩
- WHO — Current HIV and AIDS fact sheet: advanced-disease definitions and care. Source. ↩
- NIH/DHHS — Initiation of ART: disease progression, treatment benefits and clinical considerations. Source. ↩
- NIAID — HIV Long-Term Non-Progressor Study. Definition of long-term non-progressors and elite controllers as a small group whose immune systems control HIV without medication. ↩ ↩
- Trickey et al., Lancet HIV (2023);10:e295–e307. Adults in Europe/North America surviving at least one year on ART; primary record and full text. Source. ↩ ↩
- HIV.gov — Symptoms of HIV. The three stages of HIV and the fact that many people have no symptoms during chronic infection. ↩
- CDC — National HIV Prevention and Care Objectives, May 18, 2026: provisional 2024 data reported through December 2025. Source. ↩↩
- Florida DOH — State of the HIV Epidemic, 2023. 1,981 Florida stage 3 diagnoses in 2023 (8.7 per 100,000) and the statewide care continuum for 128,497 people living with HIV. ↩ ↩
- NIH/DHHS — Prompt ART, opportunistic-infection timing exceptions and treatment for elite controllers. Source. Checked September 21, 2026. ↩ ↩ ↩ ↩ ↩
- INSIGHT START Study Group, NEJM (2015) — Immediate versus deferred ART; serious AIDS/non-AIDS events or death. Source. Checked September 21, 2026. ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.